Clinical Trials Directory

Trials / Terminated

TerminatedNCT03288766

SHERLOCK 3CG™ Diamond Tip Confirmation System

A Single-Arm Prospective, Multi-Centered Study to Assess the SHERLOCK 3CG™ Diamond Tip Confirmation System

Status
Terminated
Phase
Study type
Observational
Enrollment
232 (actual)
Sponsor
C. R. Bard · Industry
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

This study is a single-arm, prospective, multi-center study to assess clinical performance of the SHERLOCK 3CG™ Diamond Tip Confirmation System (TCS) with MODUS II software for confirming correct tip position of peripherally inserted central catheters (PICCs) in adult subjects with altered cardiac rhythm.

Detailed description

This study is intended to confirm the accuracy of the SHERLOCK 3CG™ Diamond TCS with the addition of MODUS II (SLM2) software to eliminate the need for post-procedural chest x-ray (CXR) in adult subjects with cardiac abnormalities that alter presentation of the P-wave. Atrial fibrillation will be the primary target while data on pacemaker driven rhythms and other arrhythmia types will also be collected to explore overall performance.

Conditions

Interventions

TypeNameDescription
PROCEDUREPICC placement with SHERLOCK 3CG™ Diamond TCS with MODUS II softwareThe SHERLOCK 3CG™ Diamond Tip Confirmation System (TCS) is an FDA-cleared fully-integrated magnetic tracking and ECG-based PICC tip confirmation technology, indicated for use as an alternative to chest x-ray and fluoroscopy for PICC tip placement confirmation in adult patients without any alterations of cardiac rhythms that change the normal presentation of the P-wave. A software package, MODUS II, has been developed to accurately analyze the entire ECG complex and identify the correct placement of the PICC tip based on a patient's individual ECG, in the absence of an easily identifiable P-wave. This software system is designed to provide visual and/or audio cues to notify the PICC placer of the location of the PICC tip relative to the cavoatrial junction (CAJ) of the patient.

Timeline

Start date
2018-04-19
Primary completion
2021-06-15
Completion
2021-06-15
First posted
2017-09-20
Last updated
2021-10-20

Locations

8 sites across 2 countries: United States, Australia

Source: ClinicalTrials.gov record NCT03288766. Inclusion in this directory is not an endorsement.